Common Belief regarding the emergence of AMR is misuse & overuse of antibiotics in therapy and food production system. This presentation deals with the New Dimension of AMR revealing role of Producers, Distributors, Administrators and Regulators of Antibiotics in Indian perspective.
Unusual causes of emergence of antimicrobial drug resistanceBhoj Raj Singh
Overuse and misuse of antibiotics have long been believed to fuel antimicrobial resistance (AMR), but new research shows that simply lowering consumption is not enough. Poor sanitation, corruption and low public health spending have a bigger role in pushing up drug-resistant infections in low- and middle-income countries, including India.
The Drugs and Magic Remedies (Objectionable Advertisements) Act is an Act No. 21 of 1954, which came in force on 1st of April 1955.
AIM: To control the Ad. Of drugs in certain cases, to prohibit the ads. For certain purposes for remedies alleged to possess magic qualities & to provide for related matters
Unusual causes of emergence of antimicrobial drug resistanceBhoj Raj Singh
Overuse and misuse of antibiotics have long been believed to fuel antimicrobial resistance (AMR), but new research shows that simply lowering consumption is not enough. Poor sanitation, corruption and low public health spending have a bigger role in pushing up drug-resistant infections in low- and middle-income countries, including India.
The Drugs and Magic Remedies (Objectionable Advertisements) Act is an Act No. 21 of 1954, which came in force on 1st of April 1955.
AIM: To control the Ad. Of drugs in certain cases, to prohibit the ads. For certain purposes for remedies alleged to possess magic qualities & to provide for related matters
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.
Cipla ppt presentation By Ajit R. KulkarniAjit Kulkarni
It consist of History of pharmaceutical industry, company history, prominent companies in market, SWOT analysis, Findings , Learning , Growth rate , Organisational Structure , Ownership Pattern etc.
Medicinal properties of plant terminalia bellerica(barro) which have
contain different chemical constituent and having differnt biological activity like Analgesic activity,Anti diarrhoeal activity, Antioxidant activity, Antihypertensive effect, Anti salmonella activity, Anti- Spasmodic and, Bronchodilatory properties, Anti-micobial activity, Antimicrobial and Toxicity studies, Wound healing activity
Ayurveda is a very well documented System of Health Care Practiced in Indian Sub-Continent.
Ayurvedic medicines are medicines intended for internal or external use, for or in the diagnosis ,treatment, mitigation or prevention of disease or disorder in human beings or animals.
Ayurvedic Drugs are obtained from the natural source that is from animal, plants and minerals.
Siddha system of medicine is an ancient science, which belongs to Dravidian culture. Siddha system insists the scientific mode of life. Its preliminary aim is prevention and preservation of health.
Assessment of Microbial Quality of Commercial Herbal Cosmetics v2zq
Assessment of Microbial Quality of Commercial Herbal Cosmetics - Resources for Healthy Children www.scribd.com/doc/254613619 - For more information, Please see Organic Edible Schoolyards & Gardening with Children www.scribd.com/doc/254613963 - Gardening with Volcanic Rock Dust www.scribd.com/doc/254613846 - Double Food Production from your School Garden with Organic Tech www.scribd.com/doc/254613765 - Free School Gardening Art Posters www.scribd.com/doc/254613694 - Increase Food Production with Companion Planting in your School Garden www.scribd.com/doc/254609890 - Healthy Foods Dramatically Improves Student Academic Success www.scribd.com/doc/254613619 - City Chickens for your Organic School Garden www.scribd.com/doc/254613553 - Huerto Ecológico, Tecnologías Sostenibles, Agricultura Organica www.scribd.com/doc/254613494 - Simple Square Foot Gardening for Schools - Teacher Guide www.scribd.com/doc/254613410 - Free Organic Gardening Publications www.scribd.com/doc/254609890 ~
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.
Cipla ppt presentation By Ajit R. KulkarniAjit Kulkarni
It consist of History of pharmaceutical industry, company history, prominent companies in market, SWOT analysis, Findings , Learning , Growth rate , Organisational Structure , Ownership Pattern etc.
Medicinal properties of plant terminalia bellerica(barro) which have
contain different chemical constituent and having differnt biological activity like Analgesic activity,Anti diarrhoeal activity, Antioxidant activity, Antihypertensive effect, Anti salmonella activity, Anti- Spasmodic and, Bronchodilatory properties, Anti-micobial activity, Antimicrobial and Toxicity studies, Wound healing activity
Ayurveda is a very well documented System of Health Care Practiced in Indian Sub-Continent.
Ayurvedic medicines are medicines intended for internal or external use, for or in the diagnosis ,treatment, mitigation or prevention of disease or disorder in human beings or animals.
Ayurvedic Drugs are obtained from the natural source that is from animal, plants and minerals.
Siddha system of medicine is an ancient science, which belongs to Dravidian culture. Siddha system insists the scientific mode of life. Its preliminary aim is prevention and preservation of health.
Assessment of Microbial Quality of Commercial Herbal Cosmetics v2zq
Assessment of Microbial Quality of Commercial Herbal Cosmetics - Resources for Healthy Children www.scribd.com/doc/254613619 - For more information, Please see Organic Edible Schoolyards & Gardening with Children www.scribd.com/doc/254613963 - Gardening with Volcanic Rock Dust www.scribd.com/doc/254613846 - Double Food Production from your School Garden with Organic Tech www.scribd.com/doc/254613765 - Free School Gardening Art Posters www.scribd.com/doc/254613694 - Increase Food Production with Companion Planting in your School Garden www.scribd.com/doc/254609890 - Healthy Foods Dramatically Improves Student Academic Success www.scribd.com/doc/254613619 - City Chickens for your Organic School Garden www.scribd.com/doc/254613553 - Huerto Ecológico, Tecnologías Sostenibles, Agricultura Organica www.scribd.com/doc/254613494 - Simple Square Foot Gardening for Schools - Teacher Guide www.scribd.com/doc/254613410 - Free Organic Gardening Publications www.scribd.com/doc/254609890 ~
WHO GMP Certified Manufacturing Units for Certificate of Pharmaceutical Produ...Anup Soans
There are 1329 WHO GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPP) in India as on 2015 according to this CDSCO document
List of some industry/ company that are related to biotechnology (biotech)/ confectionery and sugar technology.
this document has a concise information on : address,contact number, products that it manufactures, the production processes involved, and finally the financial status of the company.
Lloyd Pharmacy College - M pharm, B Pharm and D pharm Course AdmissionLloyd Pharmacy College
Lloyd pharmacy College located at Knowledge park II, Greater Noida, Offering D. Pharm, M. Pharm and B. Pharm Course. To know More about College visit - http://www.lloydpharmacy.edu.in/
In this slide contains pesticide used in grains, limits as per FSSAI , general detection method for pesticide in Grains and extraction procedures.
Presented by: P.Pavan Kalyan. (Department of pharmaceutical analysis).
RIPER, anantapur.
Started to create milestones, we A. R. Life Sciences Private Limited marked our presence in the year 2007 and operates in the manufacturing/servicing of Gemcitabine, Montelukast Sodium, Solifinacin Succinate, Anastrazole, Olanzapine since 5 years. Our quality services/products have always won us many appreciations from our clients. Our spontaneous performance and confident approach in offering the excellent range of Gemcitabine, Montelukast Sodium, Solifinacin Succinate, Anastrazole, Olanzapine, Pharmaceutical Intermediates that has made us to deepen our roots in the market. We A. R. Life Sciences Private Limited breathe with the aim to satisfy our clients with our smart products/services. We are a unit of highly experienced professionals who all contribute best of their potentials to offer high efficiency.
Ayurveda Research Vision 2020 by Ayurmitra Dr. K. Shiva Rama Prasad, at http://www.technoayurveda.com/
Guest lecture at DrBRKR GAC, Hyderabad, Andhra Pradesh, on 26-03-14
Journal of Pharmacy & Pharmacognosy Research volume 2, issue 1, 2014mofy09
The Journal of Pharmacy & Pharmacognosy Research (JPPRes) is an international, specialized and peer-reviewed open access journal, which publishes studies in the pharmaceutical and herbal fields concerned with the physical, botanical, chemical, biological, toxicological properties and clinical applications of molecular entities, active pharmaceutical ingredients, devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture, evaluation and marketing.
Medical segregation cohort study of bio – medical waste management
Authors:Naval Kishor Lodha, Krishna Murari, Biramchand Mewara, Gopal Sharma, Mahendra varma
Int J Biol Med Res. 2023; 14(4): 7699-7701 | Abstract | PDF File
WHO and ICH Guidelines for the Assessment of Herbal Drugijtsrd
The medicinal plant and herbal drugs products are widely used for thousands of years in all over the parts of the world. The word herbal drugs denoted plant parts or plants.That is converted into phytopharmaceuticals by means of straight forward processes including harvesting, drying, and storage. In recent few decades, growth and recognition of herbal medicine and plant products have taken a big share of healthcare.Theres the increasing awareness and general acceptability of the use of herbal drugs in todays practice Although, most of these applications are unorthodox, its however known fact that all over 80 of the world population are depends on herbal medicine and products for healthy living Where standardization and control with proper integration of recent scientific techniques and lore is incredibly important. This rise within the utilization of herbal product has also given to numerous forms of adulteration and abuse of the products leading to consumers and manufacturers disappointment. The challenge is innumerable and making the worldwide herbal market unsafe Evaluation of herbal drug showing an important and vital tool within the formulation of high quality herbal products. Herbal drug technology mainly used for converting botanical materials into medicines. Ms. Bhadane Suvarna | Dr. Takarkhede Smita | Ms. Kakade Pooja | Ms. Jaiswal Sangeeta | Ms. Kanaujiya Shreya | Ms. Khan Alqama "WHO & ICH Guidelines for the Assessment of Herbal Drug" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-3 , April 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49571.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/49571/who-and-ich-guidelines-for-the-assessment-of-herbal-drug/ms-bhadane-suvarna
Issues in Veterinary Disease Diagnosis.pptxBhoj Raj Singh
Diagnosis of a disease or a problem is the first step towards solution/ treatment/ control/ prevention.
Diagnosis is successfully. important to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that prevention and control measures can be planned and implemented.
However, in few years with the invasion of pharmaco-politics in disease control the term got vitiated.
Epidemiological Approaches for Evaluation of diagnostic tests.pptxBhoj Raj Singh
Diagnosis of a disease or a problem is the first step towards solution/ treatment. Clinical Diagnosis or Provisional Diagnosis is the first step in diagnosis and is done after a physical examination of the patient by a clinician. Clinical diagnosis may or may not be true and to reach Final diagnosis Laboratory Investigations using gross and microscopic pathological observations and determining the disease indicators are required. The diagnostic tests may be Non-dichotomous Diagnostic Tests (when continuous values are given by the test in a range starting from sub-normal to above-normal range) and Dichotomous Diagnostic Tests (when results are given either plus or minus, disease or no-disease). To make non- Dichotomous diagnostic test a Dichotomous one you need to establish the cut-off values based on reference values or Gold Standard test readings or with the use of Receiver operator characteristic (ROC) curves, Precision-Recall Curves, Likelihood Ratios, etc., and finally establishing statistical agreement (using Kappa values, Level of Agreement, χ2 Statistics) between the true diagnosis and laboratory diagnosis. Thereafter, the Accuracy, Precision, Bias, Sensitivity, Specificity, Positive Predictive value, and Negative Predictive value, of a diagnostic test are established for use in clinical practice. Diagnostic tests are also used to determine Prevalence (True prevalence, apparent prevalence) and Incidence of the disease to estimate the disease burden so that control measures can be implemented. There are several Phases in the development and use of a diagnostic assay starting from conceptualization of the diagnostic test, development and evaluation to determine flaws in diagnostic test use and Interpretation influencers. This presentation mainly deals with the epidemiological evaluation procedures for diagnostic tests.
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Bhoj Raj Singh
The importance of learning about medicines’ and vaccines’ efficacy or effectiveness trials is not only necessary to those who are developing, producing or marketing these pharmaceutical products but to the users also because: The Emergency approval of Covid-19 vaccines and many other medicines in last few years has created so much fuss to understand the reality. The lesson learnt from Covid-19 vaccine(s) by vaccine production, marketing, vaccination and finally the revenue earned by vaccine developers and producers, and political gain by politicians, is proving deleterious to the society as several vaccine(s), useless or scarcely proven safe and useful, are going to infest and some have already infested the market (the health industry). So reading this presentation may be useful to you so that you may question the authorities if any is engaged in bluffing you. The presentation talks briefly about Prevention trials, Screening trials, Treatment trials, Feasibility studies, Pilot studies, Phases in clinical trial, Multi-arm multi-stage (MAMS) trials, Global Clinical Trials, Vaccine efficacy, Vaccine safety, Emergency Use Authorization (EUA), Serious Adverse Events (SAE), SEA rules, The Vaccine Adverse Event Reporting System (VAERS), Vaccine Safety Datalink (VSD), The Advisory Committee on Immunization Practices (ACIP), Clinical Immunization Safety Assessment (CISA), CDSCO Rules Governing Clinical Trials, Schedule Y, The Ethics Committee, Empowered Committee on Animal Health, Tracking Vaccine Quality, Pre-clinical and Clinical data, Proof of Concept, Biological License Application (BLA) and Clinical hold.
Detection and Characterization of Pathotypes, Serotypes, Biotypes, Phenotypes...Bhoj Raj Singh
This presentation of my lecture, to Epidemiology students, briefs about different methods for differentiating or finding similarities among isolates of pathogens required establishing causal associations in epidemiological disease diagnosis.
Epidemiology of antigenic, genetic and biological diversity amongst pathogens...Bhoj Raj Singh
This presentation briefly describes the Antigenic, genetic and biological diversity amongst pathogens, and their origin and emergence. It also discusses with their association with different forms associated with a disease/ outbreak. The presentation also enlists diversity in strains causing some common diseases of livestock in India.
Differentiation of field isolates (wild) from vaccine strains (Marker, DIVA &...Bhoj Raj Singh
Nowadays vaccination is often reported as the cause of disease outbreaks. To ward off this misconception (vaccines are made to save the masses not to risk their lives)or to understand vaccination failures, it is necessary to understand the difference between a field strain causing the disease and a vaccine strain having attenuated virulence. This presentation talks about DIVA and DISA vaccines too.
Lumpy skin disease (LSD) Globally and in India.pptxBhoj Raj Singh
LSD has emerged as a dairy industry devastating disease in India in the last four years. First noticed in Orrisa and is now present all over India. Recurring outbreaks are now noticed in Rajasthan, Uttarakhand and other states indicating that the disease is becoming endemic in India.
Molecular determinants of pathogenicity and virulence among pathogens.pptxBhoj Raj Singh
The presentation discusses the pathogenicity and virulence of pathogens, their determinants and their interaction with the host. It talks briefly about pathogenicity, virulence, adhesions, invasions, toxins, disease, pathogenesis, pathogenicity islands (PAIs), intracellular, extracellular, bacteria, virus, fungi, prion, metazoan worms, protozoa, tuberculosis, E. coli, Salmonella, Yersinia, Mycobacterium, cytotoxins, enterotoxins, exotoxins, neurotoxins, endotoxins, in-silico, in-Vitro, in-vivo, immunohistology, haemagglutinins, spike proteins, integrins, and phagolysosomes.
Molecular epidemiology and Disease causation.pptxBhoj Raj Singh
This short presentation describes molecular epidemiology, differentiate it from genetic epidemiology, and also deals with ascertaining the cause of disease.
My research proposals, to porotect holy cow, rejected by the ICAR-IVRI in the...Bhoj Raj Singh
The presentation relates to my three research proposals, aimed at Protection of Holy cow, rejected at ICAR-ICAR-Indian Veterinary Research Institute, Izatnagar-243 122, India, in last five years
Clinical evaluation of newly advocated therapies for brucellosis in cattle and buffaloes. Duration: September 2019 to August 2021
A cross-sectional survey of Holy Cow Infectious Problems in Gaushalas (Gaushalas are protective shelters for stray cows in India). Duration: September 2022-August 2024
Explorative study on Epidemiological determinants associated with a drastic reduction in Milk Production of Dairy Animals with reference to communicable diseases. Duration: September 2022-August 2024
Animal Disease Control and Antimicrobial Resistance-A Message to Veterinary S...Bhoj Raj Singh
This presentation is for
• Introspection by all authorities before criticizing Veterinarians for an increase in AMR & to Doyens of Veterinary Science sitting mum when Vets are criticized!
• To realize that DAHD and State Animal/ Livestock Departments are:
– Fake data masters!
A realization to Doyens of Veterinary Science that they are:
– Spineless when their voice is the most needed!
– Don’t understand epidemiology to the least and make minimal attempts to improve Epidemiological understanding in veterinarians!
– The real negative thinkers!
– Suffering from an inferiority complex!
– Real killers of the holy cow!
– Interested to develop the best vet doctors but creating butchers!
– Real anti-nationals!
They talk of one health without understanding it!
– Much more!!!
Causes of Disease and Preserving Health in Different systems of Medicine.pptxBhoj Raj Singh
This presentation deals with concepts of disease causation and methods used for the alleviation of those causes to ensure health. It has briefed the causes of diseases according to Ayurvedic medicine, Unani medicine, Siddham medicine, Naturopathy, Homeopathy, Chinese medicine, Touch therapy- Reiki, Mantra therapy, and Allopathy. It also summarizes the treatments and practices in different systems of medicine. DOI: 10.13140/RG.2.2.30883.22569
AMR challenges in human from animal foods- Facts and Myths.pptxBhoj Raj Singh
This presentation talks about ÄMR: A public health threat, a “silent pandemic”.
Infections caused by Antimicrobial-drug-resistant (AMR) pathogens caused >1.27 million deaths worldwide in 2019 (low level or no surveillance) and increasing year after year which may be > million in coming decades. Covid-19 caused ~6.8 million deaths in >3 years but now the pandemic is ending but the AMR pandemic has no timeline for its ending. Many deaths are also attributed to AMR pathogens.
More antibiotic use (irrespective of the sector) = More AMR.
This presentation also talks about ways and means to mitigate the AMR pandemic. 1. Stopping the blame game. All are equally responsible for the emergence of AMR, the share of developed and educated communities is much more than poor and un-educated communities.
2. Working together: On-Line Real-Time AST Data Sharing Platform for different diagnostic and research laboratories doing AST routinely.
3. Implementing not only antibiotic veterinary and medical stewardship but antimicrobial production and distribution stewardship too.
4. Educating for Environmental health not only human, plant, and animal health.
5. AMR's solution is not in searching for alternatives to antibiotics but in establishing environmental harmony.
6. More emphasis on AMR epidemiology than on AMR microbiology and pharmacology.
7. Development of understanding that bacteria and other microbes are more essential for life on earth than the human race. Microbes can live without humans, but humans can’t without microbes.
Global-Health is of prime importance than economic growth/ greediness.
Herbal antimicrobials are considered as an important alternative to antibiotic and probable tools to mitigate emerging antimicrobial-drug-resistance (AMR). However, it is difficult to accept that microbes may not adapt to herbal antimicrobials as rapidly as to antibiotics. This is now well documented that herbal antimicrobial resistance is also common among common pathogenic microbes and genes are now known to encode herbal drug-resistance too. This lecture gives description how resistance to conventional antimicrobials impacts susceptibility of microbes for herbal antimicrobials. Lecture Scheduled on 21st February 2023, In: Antimicrobial Resistance (AMR) in Foodborne pathogens” sponsored under the ICAR-NAHEP-CAAST project by the MAFSU, Mumbai Veterinary College, at the Division of Veterinary Public Health, ICAR-IVRI from 20th February to 25th February, 2023.
Epidemiological characterisation of Burkholderia cepacia complex (Bcc) from c...Bhoj Raj Singh
The presentation is extracted from the thesis talking about
1. The presence of Bcc organisms in the clinical infections of animals.
2. Ultrasound gels as a potential source of pathogens, especially Bcc.
3. Multidrug resistance in BCCs.
4. Lack of regulatory guidelines in Indian Pharmacopeia as existing in USP.
There are hundreds of diseases of livestock and pet animals that can be printed through properly used quality vaccines. This presentation summarises different types of vaccines used by veterinarians to control/ prevent diseases. The presentation enlists the vaccine-preventable diseases of pets and livestock, and also the different vaccines used.
Major flaws in Animal Disease Control Leading to Partial Success or Failure.pptxBhoj Raj Singh
This presentation summarises major problems of Animal Disease Control Programs ongoing in India. India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation identifies problems at different levels of different ongoing disease control programs in India. The non-availability of authentic disease data and flaws in vaccine quality control are the biggest problems.
Animal Disease Control Programs in India.pptBhoj Raj Singh
India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation describes the pros and cons of different ongoing disease control programs going on in India.
Control and Eradication of Animal diseases.pptxBhoj Raj Singh
The presentation details different methods and terminologies used in disease management. It briefs about different types of disease control programs run at global, regional, and national levels. It also tells about the success and failure of different disease control programs. The presentation also briefed about methods of disease control.
The presentation summarises important methods and protocols of Clinical Microbiology. It may be useful to learners of Clinical microbiology at the undergraduate label. The presentation describes the procedures for collecting clinical samples, transport, and testing. It also describes the different methods of antimicrobial susceptibility testing and standards.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Causes of Emergence of Antimicrobial Drug Resistance: New Dimensions; & List of producers of substandard and fake antibiotics in India
1. Causes of Emergence of
Antimicrobial Drug Resistance:
New Dimensions
List of producers of substandard and fake antibiotics in India
BR Singh
Pri. Scientist & Act. Head of Epidemiology
Indian Veterinary Research Institute,
Izatnagar-243122, India
2. Causes of Emergence of AMR
Popular beliefs
• Overuse of antibiotics by humans and the routine use of
antibiotics to grow food animals faster are key causes.
• Exposure of bacteria to antimicrobials. Antibiotic
exposure of bacteria through overuse/ misuse/
irrational/ inappropriate/ sub-therapeutic doses.
• Where from antibiotic exposure come to Bacteria?
– Human consumption for therapeutic and preventive purposes.
– Veterinary use for therapeutic and preventive purposes.
– Use in food production system: Animals, birds, fish, agriculture.
– Hospital and laboratory wastes containing antimicrobials.
3. Causes of Emergence of AMR
New Dimensions
• Contamination of environment (soil, water and air) with
antimicrobials
– Pharmaceutical waste from antibiotic producing
pharmaceuticals polluting water bodies and soil to convert
natural resources to the breeding grounds for AMR bacteria.
(https://www.theguardian.com/sustainable-business/2016/oct/25/antibiotic-waste-pollution-
india-china-rivers-big-pharma-superbugs-resistance), https://metamag.org/2018/02/01/era-
of-life-saving-antibiotics-could-be-over-if-pharmaceutical-waste-not-tackled/,
https://www.statnews.com/2016/10/14/superbugs-antibiotic-resistance-india-china/.
– Indian and Chinese drug makers routinely release untreated
waste fluid containing active ingredients into surrounding soil
and waterways. (https://www.statnews.com/2016/10/14/superbugs-
antibiotic-resistance-india-china/).
– Reducing antibiotic-laden pollution from pharmaceutical
manufacturing plants is a relatively easy, affordable part of the
solution. However, in India releasing all noxious wastes in to
Ganges, its tributaries and other sacred rivers in much more
easier and cheaper than any other option just through bribes.
4. Source: January 24
2018, By Madlen
Davies , Sam
Loewenberg
https://www.theb
ureauinvestigates.
com/stories/2018-
01-24/big-
pharma-fails-to-
disclose-waste-
leaked-from-
factories
5. Modern Dimensions
• Sub-therapeutic exposure of microbes to antimicrobials comes
from the foul-play of administrators and pharmaceutical
companies in India, as:
• Misuse of antibiotics as preservative: Use of
Enrofloxacin as preservative in FMD Vaccine in India,
https://www.researchgate.net/publication/267705649_Testing_of_FMD_Vaccine_intended_to_be
_used_under_FMD-CP_of_Govt_of_India_at_CCS_NIAH_Baghpat_UP_India?_sg=-_mO-
HUl7fFptskNyZRmPrw-GZeBC7R5XZSIWMai00AO42QOqc9-
s6V4avawDLzVBDrKx9pSGmfCN1Nvk7LvHnCWwi20voqR1h4Dy0RG.xcSIPCtBcnwQecaXuz14vFbiaW
tDpOEj_F0TO6sXdhcalaZotay9K2Kh2-xF4DixVGRVN23qnEGvRGQLrpfOKw.
• Therapeutic use of sub-standard (NSQD) antibiotics in
therapy.
• Therapeutic use of non-approved antibiotics in therapy.
6. Therapeutic use of sub-standard (NSQD)
antibiotics in therapy
• Multibillion dollar business of Substandard and spurious
Antibiotics for therapeutic use.
– India is the leader.
(https://www.researchgate.net/publication/317715214_Why_India_Failed_to_Penalize_those_Responsible_for_the_C
irculation_of_Substandard_Medicines_and_Vaccines_while_China_Succeeded?_sg=-_mO-HUl7fFptskNyZRmPrw-
GZeBC7R5XZSIWMai00AO42QOqc9-
s6V4avawDLzVBDrKx9pSGmfCN1Nvk7LvHnCWwi20voqR1h4Dy0RG.xcSIPCtBcnwQecaXuz14vFbiaWtDpOEj_F0TO6sXdh
calaZotay9K2Kh2-xF4DixVGRVN23qnEGvRGQLrpfOKw).
• As per CENTRAL DRUGS STANDARD CONTROL ORGANIZATION
(CDSCO), India, about 6.3-10.64% drugs were substandard
(NSQD) and up to 0.47% were fake, in 2010 in India.
(http://www.cdsco.nic.in/writereaddata/REPORT_BOOK_13-7-10.pdf).
• Estimated business of antibiotics in India in 2009 was 6414
crores (Ganguly, 2011), in 2016, India consumed more than Rs.
15,000 crore worth of antibiotics (Dutta PTJ, 2017).
7. Global antibiotic consumption by country income classification
(India is the largest consumer of antibiotics)
(Klein et al, 2018, http://www.pnas.org/content/pnas/early/2018/03/20/1717295115.full.pdf)
8. Not
Approved
FDCs, 75,
64%
Approved
FDCs, 43,
36%
All antibiotic FDC formulations
Not
Approved
FDCs, 20,
38%
Approved
FDCs, 33,
62%
Antibiotic FDC formulations by
MNCs
Not approved Antibiotic uses in India
Not
Approved
FDCs, 55,
85%
Approved
FDCs, 10,
15%
Antibiotic FDC formulations by Indian
firms
No one is behind, neither Indian
Pharmas nor MNCs in flooding the
Indian market with “not-approved”
fixed dose combination (FDC)
antibiotics. Care takers (chaukidaars)
and policy makers are sleeping, corrupt
regulators are minting money.
9. 41
79
43
75
85
19
31
51
38
50
73
15
0
10
20
30
40
50
60
70
80
90
2013 2014 2015 2016 2017 2018
Number of NSQD antibiotics and producers in India from 2013
onward as per http://www.cdsco.nic.in
Only about 1% lots are sampled. If all lots got checked figures
may be in thousands. Lots from MNCs are rarely sampled.
A total of 186 producers ’ antimicrobia
NSQD Antibiotics reported NSQD Producers
Up to
March 18
10. Substandard & fake antibiotics/ antimicrobials producers/ suppliers in
India
2013; http://www.cdsco.nic.in
M/s. Hecatomb Laboratories Pvt. Ltd., Bagharbari, Panjabri, Guwahat
M/s Omega Biotech Ltd., 7 th Mile Stone, Dehradun Road, Roorkee
M/s Polo Pharmaceutic als (P) Ltd., 200, H.P.S.I.D.C., Ind Area, Baddi (H.P.)
M/s Vardhaman Pharma, 32 Industrial Area, Trilokpur Road, Kala Amb, Sirmour, Hariana
M/s Modern Laboratories, 45, Sector D 2, Sanwer Rd., Indore
M/s. Vaishali Pharmaceuticals, 7 th Km Stone, Jansath Road, Muzaffar nagar, Corp. Office 4299/3, Ansari Road, Daryaganj, new Delh
M/s. Aqua Vitoe Laboratories, Plot No. 4, Vill, Kunjal, Near Jharmajri, Baddi, H.P
M/s. Brahma Pharmaceuticals, Kokrajhar, Assam
M/s. Vardhaman Pharma, 32 Industrial Area, Trilokpur Road, Kala Amb, Sirmour, Hariana
M/s. Jackson Laboratories Pvt. Ltd., Majitha Road, Bye Pass, Asr-143004
M/s. Crystal Pharmaceuticals, 385, Model Town, Ambala City-134003
M/s. Alkem Laboratories, Survey No. 333/1, Kachigam, Daman 396210
M/s. Kilitch Drugs (India) Ltd., C-30/2, TTC INdl. Area, Pawane, Thane-400705
M/s. Biochem Pharmaceutical Industries Ltd., Survey No. 49/3, 51/1, 51/2, Ringanwada, Vill: Daman
M/s. Elegant Drugs (P) Ltd., R.S. No. 59/3 A Chalmatti-581204 Distt. Dharwad
M/s. Vardhaman Pharma, 32 Industrial Area, Trilokpur Road, Kala Amb, Sirmour, Hariana
M/s Hindustan Laboratories, Plot No. 5, 6, 7 Survey No. 38/2, Aliyali, Palighar (W), Thane, Maharastra
M/s Orision Pharmaceutical, 51, Industrial Estate, Ambala Cantt.
M/s ROSEATE MEDICARE, Vill. Anji P.O. Barog, Solan H.P.173212
M/s NLP Organics Pvt. Ltd., A-590, RIICO Industrial Area, Bhiwadi 301019, Rajasthan
M/s Minil Laboratories Pvt. Ltd., 26 Indl Estate, Jammu-10
M/s M. Sea Pharmaceuticals, Surajpur, Paonta Sahib, Distt. Sirmour (H.P.)
M/S MARTIN AND HARRIS LABORATOIES LTD., village Libberhedi, Mangalore, Tehsil Rorkee, Distt. Haridwar, Uttarakhand
M/s Jackson Laboratories Pvt. Ltd., Bye Pass Majitha Rd., Amritsar
M/s Ghanshyam Pharmaceuticals, 14-D, Rani Industrial Area, Rani, Kamrup-787131, Assam
M/s Polo Pharmaceuticals (P) Ltd., Pl. No. 200, HPSIDC Indl. Area, Baddi – 173 205, HP
M/s Indica Laboratories “Indica House” L.B.Shastri Road, Ahmedabad-380025
M/S Jackson Laboratories Pvt. Ltd., Amritsar
M/S Elegant Drugs (P) Ltd., R. S.59/3A Chalmatti 581204
M/S Vivek Pharmachem (I) Ltd., CPIP, Jammu 181133
M/s Ghanshyam Pharmaceuticals, 14-D, Rani Industrial Area, Rani, Kamrup-787131, Assam
M/s Lark Laboratories (India) Ltd, Post Bax No. 23 Delhi- 110020, Works at: SP-1192E, Phase – IV RIICO, Bhiwadi- 301019 Dist. Alwar, Rajasthan
M/s. G.S. Pharmaceuticals Pvt. Ltd. 1.5 KM, Mangalore- Saharanpur Road, Manglour, Roorkee, Dist. Haridwar- 2497656, UK
11. M/s. Zest Pharma, 275, Sector F, Sanwer Road, Indore
M/s Mittal Laboratories Pvt. Limited, Sara Industrial Estate Ltd.,
Village-Rampur, Selaqui, Dehradun
M/s Regent Ajanta Biotech, 86-87, Vill-Makhiyali Dundi, Peerpura
Road, Roorkee, Uttarakhand
M/s. EUROLIFE HEALTHCARE PVT.LTD., 69-A, Mittal
Chambers, Nariman Point, Mumbai
M/s Viva Pharma Pvt. Ltd., Jorhat-785005, Assam
M/s. UltratechParmaceuticals,(An ISO 9001:2000 & GMP
Certified Company) Vill.Tipra, P.O.:Barotiwala, Distt.Solan
M/s. Technical Labs & Pharma Pvt. Ltd., Plot No. 100, Sector-7,
I.I.E., Haridwar, Uttarakhand M/s. GRACURE PHARMACEUTICALS LTD., Bhiwadi
M/s. Rescuers Life Sciences Ltd., 131-132, EPIP, Phase-1, Jharmajri,
Baddi, Distt. Solan
M/s. MaxmedLifesciencesPvt Ltd., Plot-No. 5, Sec. IIDC, Sidcul,
Rudrapur
M/s Venus Biosciences Pvt. Ltd., 116, Export Promotion Indl
Park, Phase-I, Jharmajri, Baddi, Dist-Solan, 173205, Himachal
Pradesh M/s. ZEE Laboratories, 47, Industrial Area, Paonta Sahib
M/s. Venus Remedies Ltd., Hill Top Industrial Estate, Jharmajri,
EPIP, Phase-I (Extn.), Bhatoli, Kalan, Baddi
M/s. Medox Lifesciences, Plot No 222-223, Phase – III, Ind.Area,
Sansarpur-Terrace (H.P.)
M/s. Zee Laboratories, 47, Industrial Area, Paonta Sahib, Distt.
Sirmour H.P
M/s. Kwality PharmaceuticalS (P) LTD Nag Kalan, Majitha
Road, Amritsar India
M/s. Mediaid Health Care Pvt. Ltd., Plot No. 88, Sector-7, IIE,
SIDCUL, Haridwar
M/s. Ultratech Pharmaceuticals Vill. Tipra, Haripur Road, P.O.
Barotiwala, Solan (H.P.)
M/s Regent Ajanta Biotech, 86-87, Vill-Makhiyali Dundi,
Peerpura Road, Roorkee, Uttarakhand
M/s. Hecatomb Laboratory Pvt. Ltd., Baghorbori, Panjabari,
Guwahati
M/s Rainbow Laboratories, 158, New Industrial Area-II,
Manideep, Dist-Raisen- M/s. Zee Laboratories, 47, Industrial Area, Paonta Sahib
M/s Visa Drugs & Pharmaceuticals, Pvt. Limited. Gullerwala,
Near Sai Road, Baddi, Solan
M/s Lolyds Pharmaceuticals, Kalapahar Industrial Area,
Guwahati
M/s. Shivalik Remedies Pvt. Ltd., Khasra No. 509/1-2 & 520,
Village, Bhagwanpur – 247667, Dist. Haridwar, Uttarakhand M/s Apple Formulations Pvt. Ltd., Plot 208, Kishanpur, Roorkee
M/s Pharm Asia Drugs, 20-21 Panchal Compound, Survey No. 78/1,
PatwariHalke No. 17, New 45, Indore M/s CB Healthcare, Vill. Messa Tibba, Nalagarh, Solan
M/s BHC Lab (P) Ltd., 91/2, DIC Baddi, Dist. Solan, 173205, Himachal
Pradesh
M/s Laborate Pharmaceuticals India Ltd., Rajban Road,
Nariwala, Paonta Sahib
2014; http://www.cdsco.nic.in
12. 2014 continue; http://www.cdsco.nic.in
M/s Veejay Laboratories, EPIP Zone, Amingaon, Guwahati-781031,
Assam
M/s Scott-Edil Pharmacia Ltd. , 56, EPIP, Phase I, Jharmajri-
173205
M/s Viva Pharma Pvt. Ltd., Jorhat, Assam
M/s Argon Remedies Pvt. Ltd., Saverkhera Moradabad Road,
Kashipur, Uttarakhand
M/s Laborate Pharmaceuticals India Ltd., Rajban Road, Nariwala,
Paonta Sahib, Himachal Pradesh
M/s Ghanshyam Pharmaceuticals, D-14, Rani Industrial Area,
Kamrup
M/s Regent Ajanta Biotech, 86-87, Vill. MakhiyaliDundi, Peer Pura
Road, Roorkee
M/s Hecatomb Laboratory Pvt. Ltd., Bagharbari, Panjabari,
Guwahati
M/s. Brooks Laboratories Ltd., Village: Kashipura, Nalagarh Road,
Baddi
M/s. Concept Pharmaceuticals Ltd., A-28/3, MIDC,Chikalthana,
Aurgabad
M/s. Marc Laboratories Ltd. (U-III), Plot No. 112, HPSIDC, Baddi,
Solan (HP)
M/s. Vardhaman Pharma,32 Industrial Road, Kala-Amb, Sirmour,
Haryana
M/s. Not Stated
M/s. Concept Pharmaceuticals Ltd., A-28/3, M.I.D.C., Chikalthana,
Aurangabad-431006
M/s Jackson Laboratories Pvt. Ltd., Amritsar Majitha Road, Bye
Pass, Amritsar-14300 M/s. Nirma Limited (Healthcare Division), Sachana, Gujarat
M/s A.K. Biotech Pvt. Ltd., Export Promotional Industrial Park,
Kartholi Jammu
M/s. Omega Biotech Ltd., 7th Mile Stone, Dehradun Road,
Roorkee
M/s Therawin Formulation 69-71, Jasmeet Nagar, Ambala City-
M/s Hecatomb Laboratories Pvt. Ltd., Bagharbari, Panjabari,
Guwahati
M/s Hecatomb Laboratories Pvt. Ltd., Bagharbori, Panjabari,
Guwahati
M/s Laborate Pharmaceutical s India Ltd., Rajban Road, Nariwala,
Paonta Sahib, Himachal Pradesh
M/s Bee Dee Pharmaceuticals,, Kalapahar Industrial Area,
Guwahati M/s Regent Ajanta Biotech, VillMakhiyaliDund i, Roorkee
M/s. Indchemie Health Specialities Pvt. Ltd., Village-Kumrek,
Rangpo, East Sikkim
M/s Pro Laboratories (P) Ltd. Makkanpur, Bhagwanpur, Roorkee,
Dist.- Haridwar
M/s. Globela Pharma Pvt. Ltd., 357, G.I.D.C., Sachin Surat
M/s Laborate Pharmaceutical s India Ltd., Rajban Road, Nariwala,
Paonta Sahib, Himachal Pradesh
M/s. Mankind Pharma Limited, Kishanpura, Jamniwala, Teh:
Paonta Sahib, Distt. Sirmour
M/s Macleods Pharmaceutical s Ltd., MIDC, TarapurBoisar (W),
Dist.- Thane, Andheri (E), Mumbai
M/s. Karnataka Antibiotics & Pharmaceuticals Ltd., Plot No.
14, II Phase, Peenya, Bangalore
M/s Alkem Laboratories Ltd., VillThana, Baddi, Dist.-Solan,
Himachal Pradesh
M/s J. M. Remedies, Mamoore Complex, Saproon, Solan
19. Why India failed to stop production and sale of
substandard antibiotics?
1. Corruption, dishonesty, lack of nationalism, lack of humanity, greed, politics, bribed
system, undue boasting for made in India, make in India, Bhakti, Shakti, and so many
more factors. Some of the factors are dealt in a recent publication
(https://www.researchgate.net/publication/317715214_Why_India_Failed_to_Penalize_those_Responsible_for_the_Circulation_of_Substandard_Medicines_and_Vac
cines_while_China_Succeeded?_sg=-_mO-HUl7fFptskNyZRmPrw-GZeBC7R5XZSIWMai00AO42QOqc9-
s6V4avawDLzVBDrKx9pSGmfCN1Nvk7LvHnCWwi20voqR1h4Dy0RG.xcSIPCtBcnwQecaXuz14vFbiaWtDpOEj_F0TO6sXdhcalaZotay9K2Kh2-
xF4DixVGRVN23qnEGvRGQLrpfOKw).
2. Sleeping & inefficient CDSCO, evident by the fact that even after repeated faltering
defaulters are allowed to do business of life and deaths of people of India.
3. Lack of punishment or ineffective punishment to defaulters.
4. No monitoring of action on called back substandard batches.
5. Inefficient or insufficient legislation to punish the defaulters.
6. Deficient staffing, inefficient and corrupt staffing in drug regulatory authorities.
7. Lack of education & efficient health services.
8. Poverty with no value of life in hunger leading to state of indifference towards
injustice.
9. Lengthy procedure of judiciary leading to delayed justice & escape from prosecution
of culprits.
10. Biased justice in favor of mighty.
11. Criminalized society lacking human values and devoid of humanity.
12. Too many people swarming like flies and dying like dogs.
13. Exemplary sufferings of honest people in the system leading to apathy in masses for
truth and honesty.